Jaguar Gene Therapy

company

About

Jaguar Gene Therapy is accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases.

  • 51 - 100

Details

Last Funding Type
Series B
Last Funding Money Raised
$139M
Industries
Biotechnology
Founded date
Jan 1, 2019
Number Of Employee
51 - 100
Operating Status
Active

Jaguar Gene Therapy is accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$139M
Jaguar Gene Therapy has raised a total of $139M in funding over 2 rounds. Their latest funding was raised on Apr 13, 2021 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 13, 2021 Series B $139M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Jaguar Gene Therapy is funded by 1 investors. ARCH Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
ARCH Venture Partners Series B